EUVIMEDEUVIMED entdecken
Crossref

USP44 Regulates Chemoresistance Induced by ROS and the MAPK / NF ‐ κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer

Wanting Xiao, Yuming Lou, Pu Wu, Pengxiang Yang, Hao Wu, Jialu Song, Lutong Liu, Chaoyang Xu iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501369r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Wanting Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Ubiquitin Thiolesterase, Integrin beta4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Natural Science Foundation, Zhejiang Medical and Health Science and Technology Project, Jinhua Science and Technology Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (DDP) is a typical chemotherapy agent employed in gastric cancer (GC). Resistance development significantly impairs the success of GC therapy, and the essential mechanisms are not yet fully understood. Deubiquitinase enzymes are pivotal in mediating drug resistance across various cancers via ubiquitin‐mediated protein degradation. USP44, a deubiquitinase known as ubiquitin‐specific peptidase 44, is implicated in the development of tumors, their spread, and resistance to treatment, although its specific role in gastric cancer has yet to be clarified. We found a significant upregulation of USP44 expression in GC tissues compared to normal tissues, and it serves as a potential indicator of chemotherapy response and survival in GC. Through proteomic analysis, ITGB4 was recognized as a new substrate of USP44. Mechanistically, USP44 stabilizes ITGB4 via deubiquitination, thereby mitigating cisplatin resistance in GC cells by modulating ROS and the MAPK/NF‐κB pathway. In addition, ITGB4 affects the expression of P‐gp and the activity of antioxidant enzymes through the MAPK/NF‐κB pathway, thereby promoting cisplatin efflux and chemoresistance. Our research uncovers a novel mechanism behind cisplatin resistance and indicates that USP44 could be a promising therapeutic target for overcoming cisplatin resistance in gastric cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaUbiquitin ThiolesteraseIntegrin beta4Drug Resistance, NeoplasmHumansFemaleAnimalsMiceHEK293 CellsMice, NudeXenograft Model Antitumor AssaysCell Line, TumorMAP Kinase Signaling SystemCisplatinAntineoplastic AgentsRetrospective StudiesChinaOxidative Stress

Stichwörter der Autor:innen

ITGB4MAPK/NF‐κB signaling pathwayUSP44chemoresistancegastric cancerubiquitylation

Substanzen

USP44 protein, humanUbiquitin ThiolesteraseITGB4 protein, humanIntegrin beta4CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • General Surgery Department, Xiangdong Hospital Affiliated With Hunan Normal University, Liling, China.

ORCID-Profile: Chaoyang Xu

Förderung

  • Natural Science Foundation
  • Zhejiang Medical and Health Science and Technology Project
  • Jinhua Science and Technology Research Program
  • Chinese Medicine Research Program of Zhejiang Province
  • Medical and Health Research Project of Zhejiang Province
  • Jinhua Science and Technology Bureau

Zitieren

APA

Xiao, W., Lou, Y., Wu, P., Yang, P., Wu, H., Song, J., Liu, L., & Xu, C. (2025). USP44 Regulates Chemoresistance Induced by ROS and the MAPK / NF ‐ κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer. The FASEB Journal. https://doi.org/10.1096/fj.202501369r

Vancouver

Xiao W, Lou Y, Wu P, Yang P, Wu H, Song J, et al. USP44 Regulates Chemoresistance Induced by ROS and the MAPK / NF ‐ κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer. The FASEB Journal. 2025. doi:10.1096/fj.202501369r

BibTeX
@article{Xiao2025,
  author = {Xiao, Wanting and Lou, Yuming and Wu, Pu and Yang, Pengxiang and Wu, Hao and Song, Jialu and Liu, Lutong and Xu, Chaoyang},
  title = {USP44 Regulates Chemoresistance Induced by ROS and the MAPK / NF ‐ κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501369r}
}
Kostenlos starten →